Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 30 April 2025
- Conf. stmt due
- 6 May 2027
- Last conf. stmt
- 22 April 2026
Wild Bioscience Ltd
- Incorporated
- 23 April 2021 (5 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Lisa Michelle FlashnerCharles David Nicholson
- Owned by
- Lawrence EllisonPaul Timothy Marinelli
- Accounts type
- Small
- Region
- South East
- Address
- 115K Olympic Avenue 115K Olympic AvenueMilton ParkAbingdonOX14 4SA
Officers 5 active
Officer details are public data from the Companies House register.
Flashner, Lisa Michelle
Director · Appointed 14 October 2025
American
Born May 1967 (59)
Nicholson, Charles David, Dr
Director · Appointed 22 September 2022
British,American
Born July 1954 (72)
Director · Appointed 27 July 2021
British
Born February 1961 (65)
Hendron, Ross-William Stephen, Dr
Director · Appointed 23 April 2021
Irish
Born October 1993 (33)
Irish
Born June 1980 (46)
Officer history (1 former)
14 October 2025
Appointed Flashner, Lisa Michelle as Director
14 October 2025
22 September 2022
Appointed Nicholson, Charles David, Dr as Director
27 July 2021
27 July 2021
23 April 2021
Appointed Hendron, Ross-William Stephen, Dr as Director
23 April 2021
Ownership 3 active
People and entities with significant control, from the Companies House PSC register
Lawrence Ellison
Individual · Notified 14 October 2025
Owns 25–50% of shares (as a trust)
Holds 25–50% of voting rights (as a trust)
American
Born August 1944 (82)
Paul Timothy Marinelli
Individual · Notified 14 October 2025
Owns 25–50% of shares (as a trust)
Holds 25–50% of voting rights (as a trust)
American
Born April 1967 (59)
Corporate entity · Notified 31 March 2025
Owns 25–50% of shares
Holds 25–50% of voting rights
Private Limited Company
Reg. no. 16279473
Holdings 1
Companies where Wild Bioscience Ltd is registered as a person with significant control
Owns 75–100% of shares
Active
Former controllers (4)
31 March 2025
Ceased Oxford Science Enterprises PLC — Owns 25–50% of shares
23 December 2022
28 July 2021
Ceased Ross-William Stephen Hendron — Owns 25–50% of shares
28 July 2021
Financials
Balance sheet as at 30 April 2025 · small accounts
- Net Assets
- £2,038,185
- Cash
- £6,636,918
- Profit
- (£4,474,246)
- Employees
- 27
- Debt Ratio
- 80%
- Current Ratio
- 12.1x
- Return on Equity
- -220%
Trend
Shareholder Funds
Balance sheet detail
| 2025 | 2023 | 2022 | |
|---|---|---|---|
| Fixed Assets | £2,540,378 | £887,373 | |
| Current Assets | £7,620,720 | £4,749,216 | |
| Debtors | £296,553 | ||
| Cash | £6,636,918 | £4,452,663 | |
| Creditors (< 1 year) | £631,413 | £263,759 | £476,862 |
| Creditors (> 1 year) | £7,423,500 | ||
| Net Current Assets | £6,989,307 | £4,272,354 | |
| Net Assets | £2,038,185 | ||
| Shareholder Funds | £2,038,185 | £5,159,727 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 18 August 2026 | Other filing | |||
| 27 October 2025 | Notification of a person with significant control |
Other companies in this industry
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →